Related Experiment Video

Updated: Feb 4, 2026

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

18.3K

Preparing for the incoming wave of biosimilars in oncology

Elena Wolff-Holz1, Juan Garcia Burgos2, Rosa Giuliani3

  • 1Medicinal Policy Issues, Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Langen, Germany.

ESMO Open
|September 25, 2018
PubMed

Insights

Oncology biosimilars require stakeholder education for successful integration. Learning from other biosimilar successes and ensuring transparency in budget impacts are key to optimizing their use in cancer treatment.

Area of Science:

  • Oncology
  • Pharmacoeconomics
  • Healthcare Policy

Background:

  • The introduction of oncology biosimilars presents new opportunities and challenges in cancer care.
  • Stakeholder perspectives are crucial for understanding and optimizing the adoption of these novel therapeutic agents.

Purpose of the Study:

  • To gather and synthesize perspectives from diverse stakeholders on optimizing the uptake of oncology biosimilars.
  • To identify key strategies for the successful integration of biosimilars into cancer treatment paradigms.

Main Methods:

  • A discussion session involving clinicians, specialist nurses, patient advocates, regulators, and economists at the European Society for Medical Oncology (ESMO) Annual Congress 2017.
  • Qualitative synthesis of key messages emerging from stakeholder discussions.

Main Results:

  • Successful integration necessitates comprehensive education for all stakeholders, including healthcare professionals and patients.
  • Evidence-based decision-making and incorporating diverse voices are critical for biosimilar adoption.
  • Experience with biosimilars in other therapeutic areas offers valuable insights for oncology.
  • Sustainability of healthcare budget impacts and savings requires transparency and ongoing education.

Conclusions:

  • Optimizing oncology biosimilar uptake requires a multi-faceted approach centered on education, evidence, and inclusivity.
  • Leveraging existing biosimilar experience and ensuring financial transparency are vital for long-term success.
Keywords:
biologicalsbiosimilarscancer medicinesmonoclonal antibodiesoncology

More Related Videos

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.5K
Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology06:37

Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology

Published on: October 20, 2010

23.8K

Related Concept Videos

Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
279
The Wave Nature of Light02:12

The Wave Nature of Light

The nature of light has been a subject of inquiry since antiquity. In the seventeenth century, Isaac Newton performed experiments with lenses and prisms and was able to demonstrate that white light consists of the individual colors of the rainbow combined together. Newton explained his optics findings in terms of a "corpuscular" view of light, in which light was composed of streams of extremely tiny particles traveling at high speeds according to Newton's laws of motion.
61.4K
Wave Parameters01:10

Wave Parameters

The simplest mechanical waves are associated with simple harmonic motion and repeat themselves for several cycles. These simple harmonic waves can be modeled using a combination of sine and cosine functions. Consider a simplified surface water wave that moves across the water's surface. Unlike complex ocean waves, in surface water waves, water moves vertically, oscillating up and down, whereas the disturbance of the wave moves horizontally through the medium. If a seagull is floating on the...
9.4K
Reflection of Waves01:07

Reflection of Waves

When a wave travels from one medium to another, it gets reflected at the boundary of the second medium. A common example of this is when a person yells at a distance from a cliff and hears the echo of their voice. The sound waves (longitudinal waves) traveling in the air are reflected from the bounding cliff. Similarly, flipping one end of a string whose other end is tied to a wall causes a pulse (transverse wave) to travel through the string, which gets reflected upon reaching the wall. In...
4.6K
Half wave rectifier01:20

Half wave rectifier

A half-wave rectifier is a fundamental circuit in electronics, designed to convert alternating current (AC) voltage into a unidirectional voltage. It utilizes the simplest form of diode rectification, where the circuit comprises a single diode in series with a load resistor and an AC power source.
2.5K
Full wave rectifier01:22

Full wave rectifier

A full-wave rectifier is a device that converts alternating current (AC) to direct current (DC) and is more efficient than its half-wave counterpart. It typically includes a center-tapped transformer, two diodes, and a load resistor. The secondary winding of the transformer is divided to provide two equal voltages of opposite polarities, which is the pivotal element of full-wave rectification.
2.7K